Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

• Главные авторы: Marc-Kendy Paul (Автор), Manish Choudhary (Автор), Amy Heaps (Автор), Rinki Deo (Автор), Daniela Moisi (Автор), Kelley Gordon (Автор), John Mellors (Автор), Carlee Moser (Автор), Paul Klekotka (Автор), Alan Landay (Автор), Judith Currier (Автор), Joseph Eron (Автор), Kara Chew (Автор), Davey Smith (Автор), Scott Sieg (Автор), Urvi Parikh (Автор), Jonathan Li (Автор)
• Формат: ‌
• Опубликовано: Case Western Reserve University, 2024-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Anti-SARS-CoV-2 monoclonal antibodies (mAbs) have played a key role as an antiviral against SARS-CoV-2, but there is a potential for resistance to develop. The interplay between host antibody responses and the development of monoclonal antibody (mAb) resistance is a critical area of inve...